These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26619995)

  • 21. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
    Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis.
    Rainsbury JW; Ahmed W; Williams HK; Roberts S; Paleri V; Mehanna H
    Head Neck; 2013 Jul; 35(7):1048-55. PubMed ID: 22997051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.
    Brickman CE; Propert KJ; Merlin JS; Liu JC; Eady S; Mcghee-Jez A; Ragin C; Grover S; Cohen RB; Gross R
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):934-940. PubMed ID: 31347379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.
    Yin LX; Karp EE; Elias A; O'Byrne TJ; Routman DM; Price DL; Kasperbauer JL; Neben-Wittich M; Chintakuntlawar AV; Price KA; Ma DJ; Foote RL; Moore EJ; Van Abel KM
    Otolaryngol Head Neck Surg; 2021 Dec; 165(6):830-837. PubMed ID: 33752487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy in Metastatic Oropharyngeal Cancer.
    Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
    Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans.
    Hernandez DJ; Alam B; Kemnade JO; Huang AT; Chen AC; Sandulache VC
    Am J Otolaryngol; 2021; 42(6):103166. PubMed ID: 34333218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
    Zenga J; Graboyes E; Janz T; Drake V; Rettig E; Desai S; Nickel C; Shabani S; Padhya T; Scarpinato M; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):74-81. PubMed ID: 30753110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
    Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.
    Khalid MB; Ting P; Pai A; Russo JL; Bakst R; Chai RL; Teng MS; Genden EM; Miles BA
    Laryngoscope; 2019 Apr; 129(4):877-882. PubMed ID: 30194702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation.
    Chao HH; Schonewolf CA; Tan EX; Swisher-McClure S; Ghiam AF; Weinstein GS; O'Malley BW; Chalian AA; Rassekh CH; Newman JG; Cohen RB; Bauml JM; Aggarwal C; Lin A; Lukens JN
    Head Neck; 2019 Nov; 41(11):3858-3868. PubMed ID: 31411356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and functional outcomes of patients who underwent facial-submental artery island flap reconstruction after oral cavity or HPV-negative oropharyngeal squamous cell carcinoma ablation.
    Chen WL; Wang YY; Zhou B; Wen ZZ; Yuan KF; Chen YJ
    J Stomatol Oral Maxillofac Surg; 2020 Sep; 121(4):383-389. PubMed ID: 31783189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer.
    Aden AA; Olawuni FO; Abdel-Halim CN; Zhu AQ; Haller TJ; O'Byrne TJ; Moore EJ; Price DL; Tasche KL; Ma DJ; Lester SC; Gamez M; Neben-Wittich MA; Price K; Fuentes-Bayne HE; Routman D; Van Abel KM
    Oral Oncol; 2024 Feb; 149():106675. PubMed ID: 38211528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status.
    Lai K; Killingsworth M; Matthews S; Caixeiro N; Evangelista C; Wu X; Wykes J; Samakeh A; Forstner D; Niles N; Hong A; Lee CS
    J Oral Pathol Med; 2017 Sep; 46(8):574-582. PubMed ID: 27935119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.